ABATTIS BIOCEUTICALS CORP — Form D
ABATTIS BIOCEUTICALS CORP of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-17. The offering totals $297K, of which $297K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-03-17
- Form: D
- Accession: 0001183740-11-000197
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $297K
- Amount sold: $297K
- Investors: 3
- Date of first sale: 2010-11-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-156906
Issuer
- Name: ABATTIS BIOCEUTICALS CORP
- CIK: 0001515768
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: SUITE 1000 - 355 BURRARD STREET, VANCOUVER, A1, V6C 2G8
- Phone: 604-538-6650
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| TRAVIS S SCHNEIDER | Director | STUDIO CITY, CA |
| Nathan Hansen | Director | Heber City, UT |
| Nathan Hansen | Executive Officer | Heber City, UT |
| Mike Withrow | Director | Vancouver, A1 |
| Mike Withrow | Executive Officer | Vancouver, A1 |
| Robert J Hedley | Director | Vancouver, A1 |
| Rene J David | Executive Officer | Vancouver, A1 |
| Tim Fealey | Director | Vancouver, A1 |
| Douglas J Sorocco | Director | Vancouver, A1 |
| Yazan Al Homsi | Director | Vancouver, A1 |
| Douglas Sorocco | Director | Vancouver, A1 |
| TIMOTHY B GRZYB | Director | VANCOUVER, A1 |
| GILBERT SCHNEIDER | Director | VANCOUVER, A1 |
| ROBIN B HUTCHISON | Director | VANCOUVER, A1 |
Other filings by this issuer (4)
More